Cite
HARVARD Citation
Nakamura, T. et al. (n.d.). CD34+ cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis. Journal of gastroenterology and hepatology. 29 (10), pp. 1830-1838. [Online].